Our regular monthly trawl for new publications from HEDS in collaboration with colleagues in ScHARR and further afield has reaped a tremendous amount of fresh research. Many of these are currently in press, so you can find much of our work in its open access form via our institutional repository. Find them here.
 |
| © ISPOR |
Bermejo, I., Squires, H.,
Poku, E.N., Cooper, K., Stevens, J.W., Hamilton, J., Wong, R., Pearce, I.,
Quhill, F.M., Denniston, A.K., 2019. Adalimumab for non-infectious uveitis: is
it cost-effective? British Journal of Ophthalmology. doi:10.1136/bjophthalmol-2018-312756
Flight, L., Arshad, F.,
Barnsley, R., Patel, K., Julious, S., Brennan, A., Todd, S., n.d. A Review of
Clinical Trials with an Adaptive Design and Health Economic Analysis. Value in Health.
Franklin, M., Lomas, J.,
Walker, S., Young, T., 2019b. An Educational Review About Using Cost Data for
the Purpose of Cost-Effectiveness Analysis. Pharmacoeconomics 1–13.
doi:10.1007/s40273-019-00771-y
Lee, M.J., Dixon, S., Hind,
D., Bradburn, M., 2019. Could early total parenteral nutrition in small bowel
obstruction be cost effective? Clinical Nutrition. ESPEN 29, 265–266.
doi:10.1016/j.clnesp.2018.12.043
 |
| © Wiley |
O’Hara, J., Burke, T.,
Chowdary, P., Khair, K., Laffan, M., McLaughlin, P., Pasi, J., Stevenson, M.,
Willan, J., Hawes, C., Jain, M., Camp, C., 2019a. Key findings from an expert
validation workshop to establish an appropriate modelling framework in severe
haemophilia A, in: Haemophilia. pp. 182–183. http://eprints.whiterose.ac.uk/142723/
O’Hara, J., Jain, M.,
Stevenson, M., Burke, T., Camp, C., 2019b. Using patient-level simulation to
model patient-centric outcomes in the advent of gene therapy in severe
haemophilia A, in: Haemophilia. pp. 66–67. doi:10.1111/hae.13666
Peasgood, T., Carlton, J.,
Brazier, J., n.d. A Qualitative Study of the Views of Health and Social Care
Decision-makers on the Role of Wellbeing in Resource Allocation Decisions in
the UK. Economies 7, 14. doi:10.3390/economies7010014
Powell, P.A., Carlton, J.,
Rowen, D., Brazier, J., n.d. Producing a preference-based quality of life
measure for people with Duchenne muscular dystrophy: A mixed-methods study
protocol. BMJ Open.
Rankin, J., Rowen, D., Howe,
A., Cleland, J.G.F., Whitty, J.A., n.d. Valuing health related quality of life
in Heart Failure: A systematic review of methods to derive quality-adjusted
life years (QALYs) in trial-based cost-utility analyses. Heart Failure Review.
 |
| © Cambridge Core |
Simpson, E.L., Ren, S.,
Hock, E.S., Stevens, J.W., Binard, A., Pers, Y.-M., Archer, R., Paisley, S.,
Stevenson, M.D., Herpin, C., Ghabri, S., 2019. Rheumatoid arthritis treated
with 6-months of first-line biologic or biosimilar therapy: an updated
systematic review and network meta-analysis. International Journal of Technology Assessment in Health
Care. doi:10.1017/S0266462318003628
Squires, H., Bermejo, I.,
Poku, E.N., Cooper, K., Stevens, J., Hamilton, J., Wong, R., Denniston, A.K.,
Pearce, I., Quhill, F.M., 2019. Dexamethasone implant for non-infectious
uveitis: is it cost-effective? Br. J. Ophthalmol. bjophthalmol-2018-312765.
doi:10.1136/bjophthalmol-2018-312765
Wildman, M., Hutchings, M.,
Arden, M., O’Cathain, A., Drabble, S., Walters, S.J., Tappenden, P., Beever,
D., Whelan, P., Bradley, J., Cantrill, H., Maguire, C., Hind, D., n.d.
Development and evaluation of an intervention to support Adherence to treatment
in adults with Cystic Fibrosis: A randomised controlled trial and parallel
process evaluation protocol. doi:10.15131/shef.data.7338815
Wong, C.K.H., Tong, T.S.,
Cheng, G.H.L., Tang, E.H.M., Thokala, P., Tse, E.T.Y., Lam, C.L.K., 2019.
Direct medical costs in the preceding, event and subsequent years of first severe
hypoglycaemia requiring hospital transfer: A population-based cohort study.
Diabetes, Obesity and Metabalism. doi:10.1111/dom.13657